Chemomab Therapeutics (CMMB) EPS (Basic) (2017 - 2025)
Chemomab Therapeutics (CMMB) posted EPS (Basic) of $1226.3 for Q4 2025, up 34798761.8% on a QoQ basis from $0.0 in Q3 2025, and up 366.99% year-over-year from $262.59 in Q4 2024.
Chemomab Therapeutics (CMMB) EPS (Basic) (2017 - 2025) Analysis & Trends
Chemomab Therapeutics' EPS (Basic) history runs 9 years deep, the most recent figure standing at $1226.3 for Q4 2025.
- Quarterly EPS (Basic) rose 366.99% year-over-year to $1226.3 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1226.3 (up 366.98% YoY) and the FY2025 annual result came in at -$0.02, down 81.56% from the prior year.
- EPS (Basic) was $1226.3 for Q4 2025 at Chemomab Therapeutics, up from $0.0 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1226.3 in Q4 2025 and bottomed at -$0.01 in Q4 2021.
- A 5-year average of $82.72 and a median of $0.0 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 105.85% — and 2024, when it surged 7223623.74%.
- Chemomab Therapeutics' EPS (Basic) stood at -$0.01 in 2021, then jumped by 249.37% to $0.01 in 2022, then slumped by 59.9% to $0.0 in 2023, then jumped by 7223623.74% to $262.59 in 2024, then jumped by 366.99% to $1226.3 in 2025.
- Business Quant data shows CMMB's EPS (Basic) at $1226.3 in Q4 2025, $0.0 in Q3 2025, and $262.59 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Chemomab Therapeutics | 704.11 Mn | 693.75 Mn | - | 1,226.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,226.28 |
| Sep 30, 2025 | 0.00 |
| Dec 31, 2024 | 262.59 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | -0.01 |
| Dec 31, 2021 | -0.01 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | -688.30 |
| Sep 30, 2020 | -0.26 |